STC
MDT icon

Sarah T. Connolly’s Medtronic MDT Stock Holding History

Sarah T. Connolly’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21,514
Closed -$1.69M – 58
2023
Q3 		$1.69M Sell
21,514
-10
-0% -$837 1.11% 34
2023
Q2 		$1.9M Sell
21,524
-41
-0.2% -$3.53K 1.15% 32
2023
Q1 		$1.74M Buy
21,565
+2,439
+13% +$199K 1.1% 33
2022
Q4 		$1.49M Buy
19,126
+131
+0.7% +$10.6K 1.01% 37
2022
Q3 		$1.53M Buy
18,995
+284
+2% +$25.5K 1.12% 32
2022
Q2 		$1.68M Buy
18,711
+292
+2% +$29.6K 1.14% 33
2022
Q1 		$2.04M Buy
18,419
+718
+4% +$75.9K 1.2% 34
2021
Q4 		$1.83M Buy
17,701
+7,222
+69% +$836K 1.02% 38
2021
Q3 		$1.31M Sell
10,479
-375
-3% -$48.5K 1.08% 32
2021
Q2 		$1.35M Buy
10,854
+289
+3% +$36.3K 1.1% 37
2021
Q1 		$1.25M Sell
10,565
-48
-0.5% -$5.63K 1.11% 35
2020
Q4 		$1.24M Buy
+10,613
New +$1.17M 1.14% 36

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sarah T. Connolly's MDT Position: Q4 2023 in Review

Sarah T. Connolly sold out of Medtronic (MDT) in Q4 2023, closing a stake of 21,514 shares — an estimated $1.69M sold.

Sarah T. Connolly first reported a position in MDT in Q4 2020 and held it in 12 quarters. The position peaked at $2.04M in Q1 2022. 2,075 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Sarah T. Connolly reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • Sarah T. Connolly sold 21,514 Medtronic shares in Q4 2023, an estimated $1.69M.
  • Sarah T. Connolly first reported a position in Medtronic in Q4 2020 and held it in 12 quarters.
  • Sarah T. Connolly's Medtronic position peaked at $2.04M in Q1 2022.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Sarah T. Connolly's 13F filing for Q4 2023, filed 9 Feb 2024.